Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Drugs
Drugs
Page 11 of 30
Retail
Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit, but thousands still to come
By
Jef Feeley
,
Ashleigh Furlong
and
Bloomberg
May 24, 2024
Health
Weed beats booze as daily marijuana use outpaces drinking in definitive nationwide study of tens of millions of people
By
Carla K. Johnson
and
The Associated Press
May 22, 2024
Finance
Denmark’s economy shrinks 1.8% on reduced pharma production, showing extent of Novo Nordisk dependency
By
Sanne Wass
and
Bloomberg
May 21, 2024
Retail
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
By
Ashleigh Furlong
and
Bloomberg
May 21, 2024
Health
Justice Department formally moves to reclassify marijuana as a less dangerous drug in historic shift
By
The Associated Press
and
Lindsay Whitehurst
May 16, 2024
Companies
Employees are cheating on workplace drug tests at record rates—and legalized cannabis could be to blame
By
Christiaan Hetzner
May 15, 2024
What Medicare beneficiaries need to know about generic medications
By
Richard Eisenberg
May 15, 2024
Tech
Google DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology
By
Jeremy Kahn
May 8, 2024
Retail
Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By
Naomi Kresge
and
Bloomberg
May 2, 2024
Retail
Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark
By
Sanne Wass
,
Naomi Kresge
and
Bloomberg
May 1, 2024
Politics
Biden’s DEA to reclassify marijuana in historic shift that still doesn’t decriminalize it, sources say
By
Zeke Miller
,
Joshua Goodman
,
Jim Mustian
,
Lindsay Whitehurst
and
The Associated Press
April 30, 2024
Politics
Frustrated by high drug prices, California will offer its own version of heavily discounted Narcan to stop fentanyl overdoses
By
Adam Beam
and
The Associated Press
April 29, 2024
Newsletters
AI for drug discovery draws a $1 billion launch—and a lot of hope
By
Sage Lazzaro
April 25, 2024
Retail
AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs
By
Ashleigh Furlong
and
Bloomberg
April 25, 2024
Finance
Mexico’s meth trade has become so lucrative it is exporting the drugs as far away as Hong Kong and Australia
By
The Associated Press
April 24, 2024
Most Popular
AI
A man let ChatGPT sell his home. It beat every agent's estimate by $100K—and closed in 5 days
By
Jake Angelo
Success
Covid gave us hybrid work. The Iran War might give us a four-day week—and this time, experts say it could stick
By
Orianna Rosa Royle
Real Estate
Gen Z can’t afford a house. Some parents are choosing to fund their down payments over their college funds
By
Jake Angelo